Literature DB >> 18668559

Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis.

T A Bley1, M Reinhard, C Hauenstein, M Markl, K Warnatz, A Hetzel, M Uhl, P Vaith, M Langer.   

Abstract

OBJECTIVE: To compare the diagnostic performance of high-resolution magnetic resonance imaging (MRI) and color-coded duplex sonography (CCDS) in patients with giant cell (temporal) arteritis (GCA).
METHODS: Results of high-resolution MRI and CCDS in 59 patients with suspected GCA were compared with the final clinical diagnosis (based on the American College of Rheumatology GCA criteria and a 6-month followup study). Sensitivity, specificity, and positive and negative predictive values (PPV, NPV) were calculated for each method. In 41 of the patients, imaging results were also compared with the findings of a temporal artery (TA) biopsy.
RESULTS: Thirty-six of the 59 patients (61%) were ultimately diagnosed as having GCA. Sensitivity of high-resolution MRI and CCDS was 69% and 67%, respectively, specificity was 91% and 91%, PPV was 93% and 92%, and NPV was 66% and 64%, respectively. TA biopsy findings were positive in 24 of the 41 biopsied patients (59%). Sensitivity of high-resolution MRI and CCDS compared with TA biopsy was 83% and 79%, respectively, specificity was 71% and 59%, PPV was 80% and 73%, and NPV was 75% and 67%, respectively. The differences between high-resolution MRI and CCDS were not significant.
CONCLUSION: The diagnostic power of high-resolution MRI and CCDS in detecting GCA was comparable. Either of these noninvasive techniques may have value in the evaluation of patients with suspected GCA, and decisions regarding which technique to use may depend on the clinical setting.

Entities:  

Mesh:

Year:  2008        PMID: 18668559     DOI: 10.1002/art.23699

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

Review 1.  Recent advances in diagnostic strategies for giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  [Magnetic resonance angiography in rheumatology].

Authors:  T A Bley; B Ostendorf; A Scherer; H Kellner; W A Schmidt
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

Review 3.  Giant cell arteritis: epidemiology, diagnosis, and management.

Authors:  Miguel A Gonzalez-Gay; Cristina Martinez-Dubois; Mario Agudo; Orlando Pompei; Ricardo Blanco; Javier Llorca
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

Review 4.  [Imaging diagnostics of large vessel vasculitis].

Authors:  M Czihal; S Förster; U Hoffmann
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

Review 5.  Role of ultrasound in the understanding and management of vasculitis.

Authors:  Wolfgang A Schmidt
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-04       Impact factor: 5.346

Review 6.  [Imaging techniques for giant cell arteritis. Ultrasound and MRI].

Authors:  M Reinhard; W A Schmidt; A Hetzel; T A Bley
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

7.  [New study results for internal medicines.]

Authors:  P Stiefelhagen
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

Review 8.  [Imaging techniques in the evaluation of primary large vessel vasculitides: part 1: angiography, interventional therapy, and magnetic resonance imaging].

Authors:  M Both; B Nölle; C von Forstner; F Moosig; W L Gross; M Heller
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

9.  Why a standard contrast-enhanced MRI might be useful in intracranial internal carotid artery stenosis.

Authors:  Maximilian Oeinck; Christoph Rozeik; Jens Wattchow; Stephan Meckel; Manuel Schlageter; Christel Beeskow; Matthias Reinhard
Journal:  Neuroradiol J       Date:  2016-03-17

10.  [Imaging diagnostics in large vessel vasculitis].

Authors:  W A Schmidt; W Hartung
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.